PropertyValue
?:definition
  • Molecular assay reagents intended to identify mutations in the glypican 3 (GPC3) gene, located at chromosome Xq26.1, which may be involved in the suppression or modulation of growth in tissue and organs of mesodermal origin and may also regulate growth and tumor predisposition. Mutations at this locus have been identified in patients with encephalo-tropho-schisis syndrome, also known as Simpson-Golabi-Behmel syndrome type 1.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C3689777_UMD>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C3689777_UMD>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all